Fig. 1From: 4-cholesten-3-one decreases breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependent cholesterol transportersChemical structure of 4-cholesten-3-oneBack to article page